Skip to main content
. 2016 Apr 4;82(8):2555–2562. doi: 10.1128/AEM.03988-15

FIG 3.

FIG 3

Alignment of the deduced peptide sequence for lacticin LMG and homologous type A(II) lantibiotics, including nukacin ISK-1 from Staphylococcus warneri (GenBank accession no. Q9KWM4), lacticin 481 from Lactococcus lactis (GenBank accession no. WP_032489363), variacin from Kocuria varians (GenBank accession no. CAA63706), butyrivibriocin OR79 from Butyrivibrio fibrisolvens (GenBank accession no. AAC19355), lacticin LmgA from Lactococcus lactis (GenBank accession no. CUH82811.1), and salivaricin G32 from Streptococcus salivarius (GenBank accession no. AFB74480). Underlined amino acids, leader peptide; x, undefined residues. Gray shading and asterisks indicate identical amino acids, periods indicate amino acids belonging to similar groups, and colons indicate amino acids belonging to the same group.